Webinar Information and Registration
Achieving Hemostasis in the Operating Room and Critical Care Setting: What the Pharmacist Needs to Know
These activities have already occurred.
Wednesday, March 13, 2013
Wednesday, April 10, 2013
Thursday, May 2, 2013
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (activity # 0204-0000-13-416-L01-P).
Methods and Format
This is a live web-based activity consisting of audio, presentation slides, and an activity evaluation tool. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately following the activity. This activity is provided free of charge. View full CE processing instructions.
This continuing pharmacy education activity was planned to meet the needs of all pharmacists, especially those who are interested in the care of critically ill and surgical patients, as well as the appropriate use of emerging medications.
Bleeding is a major complication of surgery and is associated with poor clinical outcomes. A number of techniques and products for achieving surgical hemostasis are available. Although pharmacists may not be present in the surgical suite, they need to be aware of surgery-related processes that decrease the need for blood transfusions and improve patient safety in the operating room and critical care practice areas. This educational activity will review key clinical, safety, economic, and regulatory factors that pharmacists need to consider when evaluating local and systemic hemostatic agents for use in the institutional setting.
There will be time for questions and answers from the webinar audience at the end of the presentation.
After attending this knowledge-based activity, participants should be able to:
- Discuss the clinical and economic impact of surgical complications that result in bleeding and transfusion.
- Demonstrate knowledge of local and systemic hemostatic agents, including clinical, safety, economic, and regulatory factors.
- Describe the role of the health-system pharmacist in the use of hemostatic agents to manage surgical bleeding.
Professor of Clinical Pharmacy and Associate Professor of Neurosurgery
University of Tennessee Health Science Center
Bradley A. Boucher, Pharm.D., FCCP, FCCM, is Professor of Clinical Pharmacy and Associate Professor of Neurosurgery at the University of Tennessee Health Science Center in Memphis. Dr. Boucher also practices as a clinical pharmacist in the area of critical care at Regional Medical Center at Memphis.
Dr. Boucher received his Bachelor of Science and Doctor of Pharmacy degrees from the University of Minnesota and completed a critical care fellowship at the University of Kentucky. In addition, Dr. Boucher is a board-certified pharmacotherapy specialist and a fellow of the American College of Clinical Pharmacy (ACCP) and American College of Critical Care Medicine. Dr. Boucher has received several professional honors, including being elected as a pharmacy member of the National Academy of Practitioners and receiving the 2011 ACCP Clinical Practice Award.
Dr. Boucher’s current research interests include pharmacokinetic and therapeutic issues in the critically ill surgical patient and medical management of the neurotrauma patient. He has published over 75 peer reviewed articles and 15 book chapters during his career. He has also served as an editorial board member for several medical journals, including Critical Care Medicine and American Journal of Pharmaceutical Education, and he is currently serving on the editorial board of Critical Care Research and Practice. Dr. Boucher has served as President of ACCP and maintains active membership in numerous professional scientific and professional organizations, including ACCP, American Society of Health-System Pharmacists, and Society of Critical Care Medicine.
Professor of Surgery
Director Surgical Therapeutic Advancement Center
Department of Surgery
University of Virginia Health System
William D. Spotnitz, M.D., M.B.A. is director of the Surgical Therapeutic Advancement Center and professor of surgery at the University of Virginia School of Medicine in Charlottesville.
With an academic surgical career spanning more than 20 years as a cardiovascular and thoracic surgeon, Dr. Spotnitz has been active in tissue adhesive translational research, device development, and patenting and has participated in the training of more than 30 thoracic and cardiovascular surgical fellows. He founded the Tissue Adhesive Center (TAC) at the University of Virginia in 1997 and then expanded its activities as founder and director of the University’s Surgical Therapeutic Advancement Center (STAC). With 6 employees and a self generated budget of over $500,000 per year, the center facilitates multidisciplinary clinical research in surgery and related fields.
After graduating magna cum laude with an undergraduate degree in chemistry from Harvard College in Cambridge, MA, Dr. Spotnitz received his M.D. degree from the Columbia University College of Physicians and Surgeons in New York City. He completed residencies in general surgery and thoracic surgery at the Columbia Presbyterian Medical Center also in New York City. Prior to his current position, he held cardiac and thoracic surgical division chief positions at Temple University in Philadelphia, PA and the University of Florida in Gainesville, FL. In addition, Dr. Spotnitz received his M.B.A. from the University of Florida, Warrington College of Business in 2007 being elected class graduation spokesperson and a member of Beta Gamma Sigma, the international honor society for collegiate schools of business (top 20% of students).
As an internationally recognized clinical expert and a pioneer in the research and development of fibrin sealant in the United States, Dr. Spotnitz is the author or co-author of more than 160 publications, 70 of which are in the field of tissue hemostats, sealants, and adhesives. He is a nationally recognized expert in myocardial contrast echocardiography as a method of evaluating cardiac perfusion, and has received grants from both the National Institutes of Health (NIH) and the American Heart Association (AHA) to study this area.
Dr. Spotnitz has served actively as an AHA volunteer and was President of the Virginia Affiliate of the AHA. Dr. Spotnitz has also served as chair of an NIH Small Business Investigational Research funding study section.
Frequently Asked Questions for Webinars
What is a live webinar?
A live webinar brings the presentation to you – at your work place, in your home, through a staff in-service program. You listen to the speaker presentation in “real time” as you watch the slides on the screen. You will have the opportunity to ask the speaker questions at the end of the program. Please join the conference at least 5 minutes before the scheduled start time for important announcements.
How do I process my Continuing Education (CE) credit?
Continuing pharmacy education for this activity will be processed on ASHP’s new eLearning system and reported directly to CPE Monitor. After completion of the live webinar, you will process your CPE and print your statement of credit online at http://elearning.ashp.org/my-activities. To process your CPE, you will need the enrollment code that will be announced at the end of the webinar.
What if I would like to arrange for my colleagues to participate in this webinar as a group?
One person serving as the group coordinator should register for the webinar. That group coordinator will receive an e-mail confirmation with instructions for joining the webinar. A few minutes before the webinar begins, the group coordinator should launch the webinar link. Once the webinar has been activated, the coordinator will have the option to open the audio via VoIP (Voice Over IP) on the webinar toolbar or use a touch tone phone with the provided dial-in information. At the conclusion of the activity, the group coordinator will complete a brief online evaluation and report the number of participants at that site. Each participant will process his or her individual continuing education statement online.
What do I need in order to participate in the webinar?
Computer with internet access and basic system requirements. When you register, the webinar system will assess your system to ensure compatibility.
Telephone to dial the toll-free number and listen to the presentation (if you choose not to use Voice Over IP [VoIP] via your computer).
Webinar System Requirements
Be sure to view the webinar system requirements for Windows, Mac, iOS, and Android prior to the activity.